Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Short Interest Update

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) saw a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 200 shares, an increase of 100.0% from the October 31st total of 100 shares. Based on an average daily volume of 600 shares, the short-interest ratio is presently 0.3 days.

Hikma Pharmaceuticals Stock Down 1.6 %

Shares of OTCMKTS:HKMPY traded down $0.84 during trading on Friday, hitting $50.64. 633 shares of the company’s stock were exchanged, compared to its average volume of 711. The firm has a 50-day moving average price of $49.45 and a two-hundred day moving average price of $50.15. Hikma Pharmaceuticals has a 1-year low of $43.68 and a 1-year high of $55.56.

About Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.